|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-11-20
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Blocking the tubuloglomerular feedback mechanism with adenosine A1 receptor antagonists seems to improve diuresis and sodium excretion without compromising the glomerular filtration rate in patients with heart failure. However, the direct cardiac effects of this compound class have not been investigated to date.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1941-3297
|
|
pubmed:author |
pubmed-author:BöckerChristianeC,
pubmed-author:DicksteinKennethK,
pubmed-author:DodicSlobodanS,
pubmed-author:EssersHansH,
pubmed-author:GodesMichaelM,
pubmed-author:HocherBertholdB,
pubmed-author:KrotinMirjanaM,
pubmed-author:MitrovicVeselinV,
pubmed-author:NakovRoumenR,
pubmed-author:NeskovicAleksanderA,
pubmed-author:SeferovicPetarP,
pubmed-author:VerboomCeesC,
pubmed-author:ZieglerDieterD,
pubmed-author:de VoogdHankaH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
523-31
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19919976-Adenosine A1 Receptor Antagonists,
pubmed-meshheading:19919976-Cardiovascular Agents,
pubmed-meshheading:19919976-Cyclohexanes,
pubmed-meshheading:19919976-Diuresis,
pubmed-meshheading:19919976-Diuretics,
pubmed-meshheading:19919976-Dose-Response Relationship, Drug,
pubmed-meshheading:19919976-Double-Blind Method,
pubmed-meshheading:19919976-Europe,
pubmed-meshheading:19919976-Female,
pubmed-meshheading:19919976-Furosemide,
pubmed-meshheading:19919976-Glomerular Filtration Rate,
pubmed-meshheading:19919976-Heart Failure,
pubmed-meshheading:19919976-Hemodynamics,
pubmed-meshheading:19919976-Heterocyclic Compounds, 2-Ring,
pubmed-meshheading:19919976-Humans,
pubmed-meshheading:19919976-Infusions, Intravenous,
pubmed-meshheading:19919976-Kidney,
pubmed-meshheading:19919976-Kidney Diseases,
pubmed-meshheading:19919976-Kidney Function Tests,
pubmed-meshheading:19919976-Male,
pubmed-meshheading:19919976-Middle Aged,
pubmed-meshheading:19919976-Myocardium,
pubmed-meshheading:19919976-Natriuresis,
pubmed-meshheading:19919976-Receptor, Adenosine A1,
pubmed-meshheading:19919976-Stroke Volume,
pubmed-meshheading:19919976-Treatment Outcome,
pubmed-meshheading:19919976-Ventricular Function, Left
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
|
|
pubmed:affiliation |
Kerckhoff-Klinik, Department of Cardiology and Cardiosurgery, Bad Nauheim, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
